Zacks Research analyst R. Department now expects ... Redburn Atlantic assumed coverage on Quest Diagnostics in a research note on Wednesday, April 2nd. They set a “buy” rating and a $195. ...

The overall analyst sentiment from today’s analyst ... maintaining an Overweight rating with a target of $360.00. Quest Diagnostics (DGX) had its price target raised by JPMorgan Chase & Co ...

There is a lot of optimism surrounding Giants QB Jaxson Dart's potential, but here's a look at what he needs to hone in on over the coming weeks and months.

We initiate coverage on Exagen with a Buy rating, citing a promising turnaround with growing diagnostics ... from big providers (LabCorp, Quest, Arup, etc.) are entrenched. Larger autoimmune ...

InvestingPro offers comprehensive analysis of Quest Diagnostics’ performance, including 8 additional ProTips and detailed financial metrics in its Pro Research Report, part of its coverage of ...

The latest price target for Quest Diagnostics (NYSE:DGX) was reported by JP Morgan on May 6, 2025. The analyst firm set a price target for $190.00 expecting DGX to rise to within 12 months (a ...

With a market cap of $18.9 billion, Quest Diagnostics Incorporated (DGX) is a leading provider of diagnostic testing services ...

Quest Diagnostics Incorporated provides diagnostic testing and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine ...

Quest Diagnostics Incorporated (NYSE: DGX), a leader in diagnostic information services, has reached an all-time high, with its stock price soaring to $179.37.The company’s strong market ...